Developed by researchers at Israel’s Weizmann Institute and Sourasky Medical Center, the U.S. Food and Drug Administration fast-tracked the approval for their cancer treatment Yescarta, based on technology that uses the patient’s immune system to destroy cancer cells.
• List price in U.S. for the personally tailored drug is $373,000.
By Hezi Sternlicht & Israel Hayom Staff
Kite Pharma, founded by Israeli-American Professor Arie Belldegrun in 2009, has announced that the U.S. Food and Drug Administration has granted regular approval for its cancer treatment Yescarta.
California-based Gilead Sciences bought Kite Pharma for $12 billion in August this year.
Professor Arie Belldegrun – Photo: Kite Pharma
The product, which was approved on a fast-track process, is based on innovative technology that recruits the body’s immune system to identify and destroy cancer cells. Continue Reading »
Israeli researchers from the Weizmann Institute of Science have genetically engineered vegetables by infusing them with betalain pigments from beets, making them “insanely healthy.”
View original Arutz Sheva publication at:
Continue Reading »
The Weizmann Institute of Science gets ranked at 10 in computer sciences, 50 in chemistry while the Hebrew University of Jerusalem makes a significant jump in the prestigious Shanghai Ranking, to 11th place in mathematics.
The Hebrew University in Jerusalem has been ranked 11 in the field of mathematics according to the Academic Ranking of World Universities (ARWU), an annual publication of university rankings by Shanghai Ranking Consultancy, which was released on Wednesday.
This is a significant jump for the university, which was ranked 51-75 last year.Among the first 100 in math are other Israeli academic institutions, including the Technion, Tel Aviv University and the Weizmann Institute of Science. Continue Reading »
Innovative Israeli cure shows 94% of leukemia patients in clinical test in the U.S. exhibits signs of recovery.
By Israel Today Staff
An innovative Israeli-developed cure for leukemia that is currently being tested in the US is seeing amazing results.
The clinical tests have been run primarily on patients with advanced leukemia that were given only a matter of months to live. An astonishing 94 percent have reportedly shown improvement, and in more than half symptoms related to the cancer have disappeared all together.
Professor Zelig Eshhar
Professor Stanley Riddell of the University of Washington, who is running the tests, cautioned that much work remains to clarify the results of the study, and it is still unknown if the treatment managed to remove the cancer completely, or if it will return in the aforementioned patients. Continue Reading »
Having chosen to visit Israel, the 19 Chinese winers will attend 10-day science youth camp at Weizmann Institute of Science and meet Nobel chemistry laureate Professor Ada Yonath.
By Dan Lavie
Nineteen Chinese teenagers who won a prestigious science competition are scheduled to visit Israel next week as their prize. The winning group was given its choice of travel destinations, and has chosen to attend a special 10-day workshop hosted by the Weizmann Institute of Science.
Continue Reading »
Chinese students visit Israel as part of 2014’s Smart-Up Science Youth Camp
The teenagers will be accompanied by teachers, journalists, and Beijing government officials.
Centre for Science and Technology Studies (CWTS) of Leiden University in the Netherlands ranked Weizmann Institute 10th in world for scientific research quality.
An Israeli science institute has been ranked in tenth place in a list of international research institutions and universities.
Weizmann Institute of Science in the central Israeli city of Rehovot – Photo: Weizmann Institute of Science website
The Weizmann Institute of Science in the central city of Rehovot was the only institute located outside the US to be included in the ranking conducted by the Center for Science and Technology Studies (CWTS) of Leiden University in the Netherlands. Continue Reading »
Rehovot researchers discover breathing response to foul & pleasant scents in children with autism are different than other children.
A team of Israeli scientists has discovered autistic children’s unique sniffing habits may help doctors diagnose the condition at a much younger age than was previously possible.
Young girl smelling flower – Photo: AFP/Marty Melville
Doctoral student Liron Rozenkrantz and Professor Noam Sobel of the Weizmann Institute of Science in Rehovot believe the key to detecting autism in children may be reliant on the latter’s response to pleasant and unpleasant odors.
The study, titled “A Mechanistic Link between Olfaction and Autism Spectrum Disorder,” examines internal action models (IAMs), brain templates for sensory-motor coordination based on sensory reactions. Continue Reading »
About 2,500 Israelis who left Israel signed up for a program bringing academics back. Apart from job placement, the newly launched program will provide personal support for those returning: ‘We want to make sure they don’t give up & leave’
By Shahar Chai
A national plan aimed at curbing the brain drain problem was launched on Monday in the United States. The plan’s aim is to attract hundreds of expatriates from the academic world back to Israel.
Studying, working abroad. Oxford University – Photo: Shutterstock
“I want to give back to society and the economy, but I don’t have a place to do this,” said one of those who signed up for the program. Continue Reading »
What genes hold the key to longevity? Why does long life run in certain families? Could age-related diseases be conquered by slowing the aging process? Why do people lose muscle mass as they age, and why do smokers lose it faster?
Dr. Haim Cohen, left, and Dr. Yariv Kanfi in their Bar-Ilan University lab with the famous long-lived mice. – Photo: Yoni Reif
These are some of the questions Israeli biogerontologists are answering for a world where the average age is on the rise and the number of people 65 and older is expected to double by 2040. Continue Reading »
A research team from Israel’s Weizmann Institute of Science in Rehovot has discovered a tool that can see inside deep tissues and could one day do away with the need for cancer biopsies.
By Rivka Borochov
It might not give us humans Superman vision just yet, and it could take at least 10 years to develop it into a commercial product, but a new discovery by a research team from Israel’s Weizmann Institute of Science in Rehovot has paved the way for an exciting medical advance.
Weizmann Institute researchers Ori Katz, left, and Eran Small
Ori Katz and Eran Small, under the guidance of Prof. Continue Reading »